Acorah Software Products - Accounts Production 19.4.351 true true false true No description of principal activity 1 November 2024 30 November 2025 30 November 2025 16055042 Mr. Assaad Rayess iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16055042 2024-10-31 16055042 2025-11-30 16055042 2024-11-01 2025-11-30 16055042 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-11-30 16055042 frs-bus:FilletedAccounts 2024-11-01 2025-11-30 16055042 frs-bus:Micro-entities 2024-11-01 2025-11-30 16055042 frs-bus:EntityHasNeverTraded 2024-11-01 2025-11-30 16055042 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-11-30 16055042 frs-bus:Director1 2024-11-01 2025-11-30
Registered number: 16055042
Ray Pharma Limited
Unaudited Financial Statements
For the Period 1 November 2024 to 30 November 2025
Balance Sheet
Registered number: 16055042
30 November 2025
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
Ray Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16055042 . The registered office is First Floor, 244 Edgware Road, London, W2 1DS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
Page 0
Page 1
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr. Assaad Rayess
Director
19 October 2026